Methylammonium is a substrate for the ammonium transport system of Azotobacter vinelandii. During cellular uptake methylammonium is rapidly converted to a less polar metabolite (E. M. Barnes, Jr., and P. Zimniak, J. Bacteriol. 146:512-516, 1981). This metabolite has been isolated from A. vinelandii and identified as -y-glutamylmethylamide by mass spectroscopy, ,H nuclear magnetic resonance spectroscopy, and cochromatography with the authentic compound. Escherichia coli also accumulated -y-glutamylmethylamide during methylammonium uptake. The biosynthesis of -y-glutamylmethylamide in vitro required methylammonium, ATP, L-glutamate, and a soluble cell extract from A. vinelandii. The enzyme responsible for y-glutamylmethylamide synthesis was glutamine synthetase. In a crude extract, L-methionine-DL-sulfoximine was equipotent in inhibiting the activities for -y-glutamyltransferase and for the synthesis of glutamine and lyglutamylmethylamide. Likewise, an antiserum against the glutamine synthetase of E. coli precipitated the transferase and both synthetic activities at similar titers. Methylamine is used experimentally both as a substrate for ammonium transport (2, 5, 6, 13, 17, 19) and in measurement of intracellular pH (1, 7) in microorganisms. It is commonly assumed that methylamine is not metabolized, although specialized C1-utilizing microorganisms readily metabolize it. Two pathways for methylamine oxidation by methylotrophic bacteria are known (3). One of these is a mechanism involving direct conversion to formaldehyde via methylamine dehydrogenase as in Pseudomonas AMI (4). In the second, intermediates, -y-glutamylmethylamide (GMAD), N-methylglutamate, and N-methylalanine accumulate as in Pseudomonas MS (15, 20) .
Methylamine is used experimentally both as a substrate for ammonium transport (2, 5, 6, 13, 17, 19) and in measurement of intracellular pH (1, 7) in microorganisms. It is commonly assumed that methylamine is not metabolized, although specialized C1-utilizing microorganisms readily metabolize it. Two pathways for methylamine oxidation by methylotrophic bacteria are known (3) . One of these is a mechanism involving direct conversion to formaldehyde via methylamine dehydrogenase as in Pseudomonas AMI (4) . In the second, intermediates, -y-glutamylmethylamide (GMAD), N-methylglutamate, and N-methylalanine accumulate as in Pseudomonas MS (15, 20) .
In the pourse of our studies of the ammonium transporter in Azotobacter vinelandii, a N2-fixing aerobe, we found that rnethylammonium is rapidly converted to an impermeant metabolite (2) . This is surprising since A. vinelandii is not a t Present address: Department of Biochemistry and Pharmacology, Tufts University School of Medicine, Boston, MA 02111. methylotroph, nor is it able to utilize methylammonium as a nitrogen source. In this paper we report the identification of this metabolite as GMAD and the identification of glutamine synthetase as the enzyme responsible for its synthesis. The properties of methylammonium as a substrate for glutamine synthetase are also described and compared with those for membrane transport.
MATERIALS AND METHODS
A. vinelandii OP (ATCC 13705) was grown as previously described (2) , except that media were supplemented with a trace metal solution' (16) . The uptake assay of [14C]methylammonium was adapted from the method of Barnes and Zimniak (2) (see legend to Fig.  1 ). For isolation and purification of the methylammonium metabolite, the uptake assay was scaled up and modified. Cells. (500 to 1,000 mg of protein) were suspended in 30 ml of 10 Thin-layer chromatography of the material, with and without prior dansylation, was previously reported (2) . Authentic GMAD was synthesized chemically by cyclization of glutamic acid to pyroglutamic acid and by its subsequent reaction with methylamine by the method of Lichtenstein (10) . ' (11) . For kinetic studies, glutamine synthetase was purified through the acid precipitation step of Siedel and Shelton (16) . y-Glutamyltransferase activity was measured by the hydroxamate method (14) . The biosynthetic activity of glutamine synthetase in crude extracts was assayed by phosphate release (14) . In some cases with the ["4C]methylammonium substrate, the incubation mixture was adsorbed on Dowex-50 columns, and GMAD was eluted as described by Kung and Wagner (9) . For kinetic studies of the purified glutamine synthetase, the biosynthetic activity was determined by a continuous spectrophotometric assay with pyruvate kinase and lactic dehydrogenase (14) .
The procedures of Stevenson and Silver (17) were followed for the growth of Escherichia coli B and measurement of methylamine uptake. A crude antiserum against the glutamine synthetase of E. coli was provided by Earl Stadtman (National Heart, Lung, and Blood Institute). A y-globulin fraction was prepared by ammonium sulfate precipitation (40% saturation at 0°C) followed by dialysis. The final volume of the -y-globulin fraction was the same as that of the original serum. A control preimmune sheep serum was treated similarly. For immune precipitation, the -yglobulin fraction was serially diluted with a buffer containing 100 mM KCI, 1 (8, 16) . This inhibits the biosynthetic activity (NH4' as substrate) and stimulates the transferase activity (Table 2) . With methylammonium as biosynthetic substrate, the activity was also dramatically reduced in NH4+-cultured cells (Table 2) . Although the degree of inhibition appears more pronounced for the methylammonium-dependent than for the ammonium-dependent activity, the rather low rates observed place the differences nearly within experimental error. The effects of methionine sulfoximine, a potent inhibitor of glutamine synthetase (12), on these activities was also examined (Fig. 2) . At 1 p.M, this compound produced a 60% inhibition of the rates of GMAD synthesis and of transferase activity; 65% inhibition was observed for glutamine synthesis. The effects of methionine sulfoximine on all three activities were essentially the same at each concentration tested.
Immune precipitation experiments with an antiserum against the E. coli glutamine synthetase were also conducted. The -y-globulin fraction of this antiserum was previously shown to cross-react with the A. vinelandii enzyme (18) . This observation was confirmed (Fig. 3A) ; 32% of the total transferase activity (represented by 55 pg of crude extract) was precipitated by 1 [.l of immune -y-globulin. The biosynthetic activity with both ammonium and methylammonium substrates was precipitated at essentially the same titer. In no case did y-globulin from preimmune serum reduce activity.
The kinetic parameters of methylammonium and ammonium as substrates were determined with a partially purified preparation of A. vinelandii glutamine synthetase. Both substrates gave linear, monophasic Eadie-Hofstee plots (data not shown). Methylammonium gave a Vmax of 0.30 ,umol/min per mg, which was 27% of that observed for ammonium. The Km for methylammonium (78 mM) was strikingly higher than that for ammonium (0.089 mM). This suggests that the apparent affinity of glutamine synthetase for methylammonium is approximately 0.1% of that for ammonium. DISCUSSION A metabolite of methylammonium which was previously shown to accumulate in A. vinelandii (2) has now been identified as GMAD. This was demonstrated by isolation of the metabolite followed by mass spectroscopy, NMR spectroscopy, and cochromatography with chemically synthesized GMAD. Although Gordon and Moore (6) reported that only chemically unaltered methylammonium accumulates in the same strain of A. vinelandii, the chromatographic method which they employed affords little resolution of methylammonium and GMAD. We were also able to identify GMAD as the major metabolite of methylammonium in E. coli. This compound has been found in Rhizobium sp. under similar conditions (5) .
We have demonstrated that the biosynthesis of GMAD by cell extracts required both glutamate and ATP. The enzyme responsible for this reaction was glutamine synthetase, the major activity of ammonia assimilation in A. vinelandii. Glutamine synthetase was measured in crude extracts as biosynthetic activities with ammonium and methylammonium substrates. Both biosynthetic activities responded similarly to inhibition during ammonium repression experiments, inactivation by methionine sulfoximine, and immune precipitation by a specific antiserum. Likewise, a partially purified preparation of glutamine synthetase from A. vinelandii utilized methylammonium as a substrate. Woolfolk et al. (20) have shown previously that methylammonium is a weak substrate for pure preparations of glutamine synthetase from E. coli. These findings are quite different from those of Kung and Wagner (9) , who reported that a distinct GMAD synthetase is induced in Pseudomonas MS during growth on methylamines.
The observation that methylammonium is rapidly converted to GMAD places significant restrictions on its use as a transport substrate or probe for measurement of intracellular pH. Both our laboratory (2) and others (6, 19) have found methylammonium to be a useful substrate for the ammonium transport system of A. vinelandii. However, the majority of radioactivity which accumulates intracellularly is contained in GMAD, which is much less permeable than methylammonium ( Fig. 1 and reference 2) . Thus, we consider the uptake of methylammonium to be a two-step process involving a mediated translocation of solute across the cell membrane followed by its intracellular conversion to GMAD. Since the latter step represents a metabolic trapping reaction which prevents exodus of radiolabel, GMAD synthesis is likely to become rate limiting for the accumulation of label at uptake times beyond 1 min (Fig. 1) . We have also demonstrated recently that GMAD itself is an inhibitor of methylammonium uptake (Jayakumar and Barnes, Fed. Proc. 42:1941 , 1983 ), which introduces an additional complication for these measurements.
Two groups of investigators have suggested a role for glutamine synthetase in the translocation of methylammonium. Kleinschmidt and Kleiner (8) based this idea on the finding that a small fraction of glutamine synthetase activity is associated with membranes from A. vinelandii. A similar view by Gober and Kashket (5) is supported by the observation that methionine sulfoximine inhibits the uptake of methylammonium by Rhizobium sp. On the other hand, we have found a number of properties which distinguish methylammonium (ammonium) transport from glutamine synthetase. (i) The apparent affinity of uptake sites for methylammonium (Km = 25 ,uM [2] ) is more than 3 orders of magnitude higher than the corresponding affinity for glutamine synthetase (Km = 78 mM).
(ii) The uptake of methylammonium is strongly inhibited by Tl+ (Ki = 13 ,uM [2] ), whereas glutamine synthetase activity in vitro and ATP synthesis in vivo are not significantly affected by Tl+ concentrations up to 200 ,M (data not shown). (iii) Glutamine and glutamine analogs inhibited methylammonium uptake at concentrations which had no effect on glutamine synthetase activity (Jayakumar and Barnes, Fed. Proc. 42:1941 , 1983 ). Inhibition of uptake by methionine sulfoximine, also a structural analog of glutamine, is therefore likely to occur at membrane sites distinct from glutamine synthetase. (iv) Although both methylammonium uptake and glutamine synthetase biosynthetic activities are reduced by growth of cells in ammonium medium, only the uptake activity is reduced in cells exposed to methylammonium (Jayakumar and Barnes, Fed. Proc. 42:1941 , 1983 ). This demonstrates independent regulation of the two processes. Although these properties point to a transport component which clearly differs from glutamine synthetase, they do not rule out some involvement of the synthetase in methylammonium translocation. It is apparent that the GMAD metabolic trap must be eliminated experimentally for us to explore this possibility as well as provide for unequivocal measurements of methylammonium translocation. Such experiments are in progress.
